Drug
Orka 002
Orka 002: highest development phase Phase 2, developed by Oruka Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Oruka Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ORKA-002 NCT07933783 | Phase 2 | Plaque Psoriasis |
Latest
No recent events.
Follow Orka 002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.